NexaBiome

Private

GlasgowHealthcare & Life Scienceshttps://nexabiome.com/

Last Round

Grant

Jan 22, 2026

Total Funding Raised

$2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NexaBiome is a biotechnology company that develops bacteriophage solutions to combat antimicrobial resistance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

phage therapyantimicrobial resistanceAMRbacteriophage technologyphage stabilizationantibiotic alternativesdrug-resistant infectionssuperbug treatmentphage formulationanimal healthhuman healthwound carephage librarybiotechnology licensinglivestock healthaquaculture health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NexaBiome Comps

Public and private peers based on sector, stage, and business model.

NexaBiome comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NexaBiome Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jan 22, 2026
VC Round	Jan 2, 2024
Follow-on Offering	Dec 14, 2022
VC Round	Mar 15, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Jason Clark

Chief Executive Officer, Chief Scientific Officer

Executive Team

NexaBiome Investors

Notable investors and investment history

NexaBiome investors
Investor	Rounds
London & Scottish Investment Partners	Follow-on Offering, VC Round
Scottish Investment Bank (Scottish Enterprise)	Follow-on Offering, VC Round, Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 22, 2026
$170K grant received from Scottish Investment Bank.
Jan 2, 2024
Raised $13M in a venture round.

View all signals

NexaBiome Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NexaBiome Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NexaBiome's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow

Employee Range13

Year Founded2010

Last FundingJan 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.